Literature DB >> 26793362

Unidirectionally progressive resection of lower left lung carcinoma under video-associated thoracoscopy.

Kaican Cai1, Yan Yan1, Siyang Feng1, Xiguang Liu1, Hua Wu1, Jin Ye1, Sue Liu1, Yuan Liu1, Mei Li1.   

Abstract

General anesthesia is adopted through double-lumen endotracheal intubation, one-lung ventilation on the contralateral, and intravenous injection. The patient took a 90 degree decubitus on his contralateral side. The operative incisions: the observation port was made in the mid-axillary line of the 7(th) intercostal section, a second horizontal incision of 4 cm as the main operation port at the 4(th) intercostal space between the anterior axillary line and the midclavicular line, and a 3(rd) incision of 1.5 cm as the secondary operation hole at the 9(th) intercostal space between the axillary line and the bottom scapular line. The surgeons were on the ventral side of the patient, and operated with endoscope apparatus in front of the monitor screen.

Entities:  

Keywords:  Video-assisted thoracic surgery (VATS); lower left lobe lobectomy; lung adenocarcinoma

Year:  2015        PMID: 26793362      PMCID: PMC4703662          DOI: 10.3978/j.issn.2072-1439.2015.12.49

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  7 in total

1.  Unidirectionally progressive resection of lower left lung carcinoma under video-associated thoracoscopy.

Authors:  Kaican Cai; Yan Yan; Siyang Feng; Xiguang Liu; Hua Wu; Jin Ye; Sue Liu; Yuan Liu; Mei Li
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

Review 2.  Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer.

Authors:  Tristan D Yan; Deborah Black; Paul G Bannon; Brian C McCaughan
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

3.  Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy.

Authors:  Nestor R Villamizar; Marcus D Darrabie; William R Burfeind; Rebecca P Petersen; Mark W Onaitis; Eric Toloza; David H Harpole; Thomas A D'Amico
Journal:  J Thorac Cardiovasc Surg       Date:  2009-08       Impact factor: 5.209

4.  Unidirectionally progressive resection of left upper pulmonary lobe under video-assisted thoracoscopy.

Authors:  Kaican Cai; Hancheng Zhao; Hua Wu; Siyang Feng; Pengfei Ren; Ruijun Cai; Gang Xiong
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

5.  Unidirectionally progressive left pneumonectomy & mediastinal lymph node dissection.

Authors:  Kaican Cai; Pengfei Ren; Siyang Feng; Hua Wu; Zhiyong Huang; Haofei Wang; Gang Xiong; Ziliang Zhang
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

6.  Unidirectionally progressive resection of lower right lung cancer under video-assisted thoracoscopy.

Authors:  Kaican Cai; Hua Wu; Pengfei Ren; Ruijun Cai; Gang Xiong; Haofei Wang
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

7.  Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer.

Authors:  Raja M Flores; Bernard J Park; Joseph Dycoco; Anna Aronova; Yael Hirth; Nabil P Rizk; Manjit Bains; Robert J Downey; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2009-07       Impact factor: 5.209

  7 in total
  2 in total

1.  Unidirectionally progressive resection of lower left lung carcinoma under video-associated thoracoscopy.

Authors:  Kaican Cai; Yan Yan; Siyang Feng; Xiguang Liu; Hua Wu; Jin Ye; Sue Liu; Yuan Liu; Mei Li
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

2.  Comparison of the perioperative efficacy between single-port and two-port video-assisted thoracoscopic surgery anatomical lung resection for non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Wenlong Yang; Guozhong Zhang; Shu Pan; Zhihao Wang; Jianfeng Li; Weidong Ren; Hongcan Shi
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.